Skip to main content

Relay Therapeutics, Inc.

RLAY
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001812364

In the last 90 days, Relay Therapeutics, Inc. insiders filed 0 open-market purchases and 14 sales; 259 institutions reported holding it in 13F filings for Q2 2026, worth $4.58B in total; Duquesne Family Office is the only superinvestor holding it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Relay Therapeutics, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
14 filings
5 insiders, $121.7M in total
Insiders trading
5
Net value
−$121.7M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Relay Therapeutics, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Relay Therapeutics, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Bergstrom Donald APresident, R&D399,130Sep 9, 20268
Catinazzo ThomasChief Financial Officer122,851Sep 9, 202612
Patel SanjivPresident and CEO519,500Sep 9, 20266
Rahmer PeterSee remarks223,657Aug 28, 20267
SB Investment Advisers (UK) Ltd10% Owner21,904,963IndirectAug 28, 20261
Softbank Vision Fund (Aiv M2) L.P.10% Owner21,904,963IndirectAug 28, 20261
SVF Pauling (Cayman) Ltd10% Owner21,904,963IndirectAug 28, 20261
Hill Linda ADirector–Jun 10, 20261
Ingram Douglas SDirector–Jun 10, 20261
Borisy AlexisDirector–Jun 10, 20261
Coats LonnelDirector–Jun 10, 20262
Dable Habib JDirector–Jun 10, 20262
Murcko MarkDirector996,952Jun 10, 20261
Mazumdar ClaireDirector–Jun 10, 20261
Adams BrianChief Legal Officer371,472Jul 30, 20250
Rubin JamiDirector67,242Jun 6, 20250
Kathiresan SekarDirector–Jun 6, 20250
Shawver LauraDirector40,000Jun 5, 20240
Porter AndyChief Administrative Officer45,164Nov 1, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 13, 2021 (view filing)Sep 13Same dayCatinazzo ThomasSenior Vice President, FinanceSSale−22.5K$35.00−$787.5K−59.1%15.6K after
Sep 13, 2021 (view filing)Sep 13Same dayAdams BrianGeneral CounselSSale−6.50K$35.02−$227.6K−20.3%25.6K after
Sep 27, 2021 (view filing)Sep 27Same dayAdams BrianGeneral CounselSSale−293$36.87−$10.8K−1.1%25.3K after
Sep 27, 2021 (view filing)Sep 27Same dayBergstrom Donald ASee RemarksSSale−646$36.87−$23.8K−0.8%75.6K after
Sep 27, 2021 (view filing)Sep 27Same dayCatinazzo ThomasSenior Vice President, FinanceSSale−293$36.87−$10.8K−1.9%15.3K after
Oct 19, 2021 (view filing)Oct 154 daysBergstrom Donald ASee RemarksSSale−30.0K$34.15−$1.02M−39.7%45.6K after
Nov 16, 2021 (view filing)Nov 151 dayAdams BrianGeneral CounselSSale−6.50K$35.42−$230.2K−20.5%25.3K after
Nov 16, 2021 (view filing)Nov 151 dayCatinazzo ThomasSenior Vice President, FinanceSSale−22.5K$35.40−$796.5K−59.5%15.3K after
Dec 27, 2021 (view filing)Dec 27Same dayAdams BrianGeneral CounselSSale−295$33.10−$9.76K−1.2%25.0K after
Dec 27, 2021 (view filing)Dec 27Same dayBergstrom Donald ASee RemarksSSale−649$33.10−$21.5K−1.4%45.0K after
Dec 27, 2021 (view filing)Dec 27Same dayCatinazzo ThomasSenior Vice President, FinanceSSale−295$33.10−$9.76K−1.9%15.0K after
Dec 27, 2021 (view filing)Dec 27Same dayPorter AndySee RemarksSSale−260$33.10−$8.61K−1.1%23.1K after
Feb 22, 2022 (view filing)Feb 22Same dayBergstrom Donald APresident, R&DSSale−23.0K$20.94−$481.6K−19.5%94.9K after3 lots
Mar 3, 2022 (view filing)Mar 12 daysBergstrom Donald APresident, R&DSSale−8.00K$23.88−$191.0K−7.8%94.9K after
Mar 11, 2022 (view filing)Mar 101 dayBergstrom Donald APresident, R&DSSale−10.0K$25.00−$250.0K−9.5%94.9K after
Mar 28, 2022 (view filing)Mar 244 daysBergstrom Donald APresident, R&DSSale−10.0K$30.00−$300.0K−9.5%94.9K after
Mar 28, 2022 (view filing)Mar 244 daysCatinazzo ThomasChief Financial OfficerSSale−13.3K$30.00−$398.6K−19.7%54.3K after
Mar 31, 2022 (view filing)Mar 292 daysAdams BrianChief Legal OfficerSSale−333$29.87−$9.95K−0.5%64.6K after
Mar 31, 2022 (view filing)Mar 292 daysBergstrom Donald APresident, R&DSSale−622$29.87−$18.6K−0.7%94.3K after
Mar 31, 2022 (view filing)Mar 292 daysCatinazzo ThomasChief Financial OfficerSSale−282$29.87−$8.42K−0.5%54.0K after
Mar 31, 2022 (view filing)Mar 292 daysPorter AndyChief Administrative OfficerSSale−294$29.87−$8.78K−0.6%47.0K after
Apr 5, 2022 (view filing)Apr 14 daysBergstrom Donald APresident, R&DSSale−18.0K$30.32−$545.8K−16.0%94.3K after
Apr 14, 2022 (view filing)Apr 12-142 daysPatel SanjivPresident and CEOSSale−84.0K$31.42−$2.64M−24.9%253.7K after5 lots
May 2, 2022 (view filing)Apr 284 daysAdams BrianChief Legal OfficerSSale−708$25.57−$18.1K−1.1%63.9K after
May 2, 2022 (view filing)Apr 284 daysCatinazzo ThomasChief Financial OfficerSSale−725$25.57−$18.5K−1.3%53.3K after
May 2, 2022 (view filing)Apr 284 daysPorter AndyChief Administrative OfficerSSale−435$25.57−$11.1K−0.9%46.6K after
May 2, 2022 (view filing)Apr 28-May 24 daysBergstrom Donald APresident, R&DSSale−14.8K$24.74−$366.4K−13.8%92.5K after2 lots
Jun 28, 2022 (view filing)Jun 24-274 daysBergstrom Donald APresident, R&DSSale−9.00K$20.03−$180.3K−9.0%91.5K after2 lots
Jun 28, 2022 (view filing)Jun 271 dayAdams BrianChief Legal OfficerSSale−300$20.31−$6.09K−0.5%63.6K after
Jun 28, 2022 (view filing)Jun 271 dayCatinazzo ThomasChief Financial OfficerSSale−300$20.31−$6.09K−0.6%53.0K after
Jun 28, 2022 (view filing)Jun 271 dayPorter AndyChief Administrative OfficerSSale−265$20.31−$5.38K−0.6%46.3K after
Jul 8, 2022 (view filing)Jul 62 daysBergstrom Donald APresident, R&DSSale−8.00K$20.00−$160.0K−8.0%91.5K after
Jul 29, 2022 (view filing)Jul 281 dayAdams BrianChief Legal OfficerSSale−734$21.27−$15.6K−1.2%62.8K after
Jul 29, 2022 (view filing)Jul 281 dayBergstrom Donald APresident, R&DSSale−1.83K$21.27−$39.0K−2.0%89.7K after
Jul 29, 2022 (view filing)Jul 281 dayCatinazzo ThomasChief Financial OfficerSSale−734$21.26−$15.6K−1.4%52.2K after
Jul 29, 2022 (view filing)Jul 281 dayPorter AndyChief Administrative OfficerSSale−452$21.27−$9.61K−1.0%45.9K after
Aug 8, 2022 (view filing)Aug 53 daysBergstrom Donald APresident, R&DSSale−8.00K$20.00−$160.0K−8.2%89.7K after
Aug 25, 2022 (view filing)Aug 241 dayBergstrom Donald APresident, R&DSSale−15.0K$25.00−$375.0K−14.3%89.7K after
Sep 1, 2022 (view filing)Sep 1Same dayBergstrom Donald APresident, R&DSSale−8.10K$23.07−$186.9K−8.3%89.7K after
Sep 2, 2022 (view filing)Sep 2Same dayBergstrom Donald APresident, R&DSSale−4.90K$25.46−$124.8K−5.2%89.7K after
Sep 8, 2022 (view filing)Sep 8Same dayBergstrom Donald APresident, R&DSSale−25.0K$30.00−$750.0K−21.8%89.7K after
Sep 8, 2022 (view filing)Sep 8Same dayCatinazzo ThomasChief Financial OfficerSSale−26.3K$30.00−$787.7K−33.5%52.2K after
Sep 8, 2022 (view filing)Sep 8Same dayMurcko MarkDirectorSSale−25.0K$29.95−$748.8K−2.4%997.0K after
Sep 15, 2022 (view filing)Sep 13-152 daysPatel SanjivPresident and CEOSSale−42.0K$24.24−$1.02M−14.2%254.6K after3 lots
Sep 29, 2022 (view filing)Sep 272 daysAdams BrianChief Legal OfficerSSale−294$22.73−$6.68K−0.5%62.5K after
Sep 29, 2022 (view filing)Sep 272 daysBergstrom Donald APresident, R&DSSale−976$22.73−$22.2K−1.1%88.7K after
Sep 29, 2022 (view filing)Sep 272 daysCatinazzo ThomasChief Financial OfficerSSale−443$22.73−$10.1K−0.8%51.8K after
Sep 29, 2022 (view filing)Sep 272 daysPorter AndyChief Administrative OfficerSSale−259$22.73−$5.89K−0.6%45.6K after
Oct 4, 2022 (view filing)Oct 31 dayBergstrom Donald APresident, R&DSSale−8.00K$22.43−$179.4K−8.3%88.7K after
Oct 13, 2022 (view filing)Oct 11-132 daysPatel SanjivPresident and CEOSSale−42.0K$21.04−$883.7K−14.2%254.6K after3 lots